Novartis Oncology Group Engineering Manager Salaries in New Haven, CT
The average Novartis Oncology Group Engineering Manager in New Haven, CT earns an estimated $205,858 annually, which includes an estimated base salary of $165,327 with a $40,531 bonus. Novartis Oncology's Group Engineering Manager compensation is $35,421 more than the US average for a Group Engineering Manager. Group Engineering Manager salaries at Novartis Oncology in New Haven, CT can range from $100,000 - $490,000.
In New Haven, CT, The Engineering Department at Novartis Oncology earns $660 more on average than the Business Development Department.
Last updated 3 years ago.
- $165,327
- avg. base
- $40,531
- avg. bonus
Group Engineering Manager Salaries at Novartis Oncology
In New Haven, CT, Group Engineering Managers earn $3,841 more than Group Engineering Managers, and $9,043 less than Directors of Engineering.
Compensation at Novartis Oncology by Department
In New Haven, CT, The Engineering Department averages $660 more than the Business Development Department, and $10,660 less than the Product Department
Group Engineering Manager Compensation by Gender (All Companies)
The average female Group Engineering Manager at companies similar size to Novartis Oncology reported making $161,172, while the average male Group Engineering Manager at similar sized companies reported making $208,878.
Group Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Group Engineering Manager at companies similar size to Novartis Oncology reported making $241,524, while the average African American/Black Group Engineering Manager at similar sized companies reported making $138,333.
How Group Engineering Managers at Novartis Oncology Rate Their Compensation
The majority of Group Engineering Managers at Novartis Oncology believe they're not compensated fairly. 100% of Group Engineering Managers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
